Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122718) titled 'Clinical Study on Dihydroartemisinin Suppressing Inflammation and Immune Dysregulation in HIV-Infected Patients' on April 16.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Beijing Youan Hospital, Capital Medical University
Condition:
HIV
Intervention:
DHA combined with ART treatment group (high-dose DHA group):High-dose DHA combined with ART intervention
DHA treatment group (not receiving ART):DHA(Dihydroartemisinin)
Conventional ART treatment group (INRs control group): ART(Antiviral Therapy) intervention
DHA combined with ART treatment group (low-dose DHA group):...